Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

WOONSOCKET, R.I. - CVS Health (NYSE: CVS )周一宣布，其董事会已批准对公司普通股每股派发0.665美元的季度股息。 根据这家医疗保健公司的新闻声明，该股息将于2025年8月1日支付给截至2025年7月22日的在册股东。

CVS Health Corp. closed 8.04% below its 52-week high of $72.51, which the company achieved on May 1st.

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The ...

Investing.com - TD Cowen维持了对CVS Health (NYSE:CVS)的买入评级和95.00美元的目标价，表示该公司可能从Centene (NYSE:CNC)面临的挑战中受益。根据InvestingPro数据，Centene目前的市盈率为5.23，分析师目标价在45美元至92美元之间，反映了市场在当前挑战下的复杂情绪。 该公司分析指出，影响Centene健康保险交易所( ...

2025年7月1日，药品零售公司西维斯（CVS）成交额为3.29亿美元，在当日美股中排第293名，成交额较昨日减少20.99%，当日成交量为472.45万。 西维斯（CVS）于2025年7月1日涨0.86%，报69.57美元，该股过去5个交易日涨2.94%，整个7月涨0.86%，年初至今涨54.98%，过去52周涨19.64%。 *如果公司上市时间少于52周，则52周涨跌幅为上市至今涨跌幅（同样适 ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Shares of CVS Health are trading higher Thursday afternoon. The stock is climbing after a GOP healthcare bill hit a roadblock ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...